GAMMA Investing’s Adaptive Biotechnologies ADPT Stock Holding History

GAMMA Investing’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Sell	13,113 -68	-0.5%	-$1.04K	0.01%	1021
2026 Q1	$183K	Buy	13,181 +60	+0.5%	+$956	0.01%	1187
2025 Q4	$213K	Buy	13,121 +181	+1%	+$2.95K	0.01%	992
2025 Q3	$194K	Buy	12,940 +16	+0.1%	+$195	0.01%	1005
2025 Q2	$151K	Sell	12,924 -469	-4%	-$4.26K	0.01%	1111
2025 Q1	$99.5K	Buy	13,393 +3,583	+37%	+$27.5K	0.01%	1260
2024 Q4	$58.8K	Buy	+9,810	New	+$54.1K	0.01%	1534
2024 Q3	–	Sell	-216	Closed	-$782	–	3578
2024 Q2	$782	Sell	216 -191	-47%	-$606	﹤0.01%	3115
2024 Q1	$1.31K	Hold	407	–	–	﹤0.01%	2878
2023 Q4	$1.49K	Buy	+407	New	+$1.86K	﹤0.01%	2674

Other funds holding ADPT

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

AWM

Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ITFISA

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Warsaw $300M AUM 61.93% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

GAMMA Investing's ADPT Position: Q2 2026 in Review

GAMMA Investing reduced its Adaptive Biotechnologies (ADPT) stake by 0.52% in Q2 2026, selling an estimated $1.04K and leaving 13,113 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #1021.

GAMMA Investing first reported a position in ADPT in Q4 2023 and has held it in 10 quarters since. 32 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

GAMMA Investing held 13,113 shares of Adaptive Biotechnologies worth $281K as of Q2 2026.
GAMMA Investing sold 68 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.04K.
Adaptive Biotechnologies made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1021 holding.
GAMMA Investing first reported a position in Adaptive Biotechnologies in Q4 2023 and has held it in 10 quarters since.
32 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.